Advances in the prevention and treatment of hepatocellular carcinoma recurrence after liver transplantation
DOI:10.3969/j.issn.1001-5256.2021.02.006
- VernacularTitle:肝移植术后肝癌复发防治进展
- Author:
Zhaobo LIU
1
;
Guangming LI
Author Information
1. Department of General Surgery, Beijing YouAn Hospital, Capital Medical University, Beijing 100069, China)
- Publication Type:Research Article
- Keywords:
Carcinoma, Hepatocellular;
Liver Transplantation;
Recurrence;
Therapeutics
- From:
Journal of Clinical Hepatology
2021;37(2):267-271
- CountryChina
- Language:Chinese
-
Abstract:
Liver transplantation is an effective radical treatment method for patients with hepatocellular carcinoma (HCC), but HCC recurrence after liver transplantation seriously affects the long-term survival of patients receiving transplantation. Active preventive measures, adjustment of immunosuppressant, early identification of HCC recurrence, and development of comprehensive intervention measures after recurrence can help to improve the clinical outcome and long-term survival of HCC patients receiving liver transplantation. In order to further improve the prognosis of patients receiving liver transplantation, this article summarizes the latest research advances in the prevention and treatment of HCC recurrence after liver transplantation from the aspects of recurrence prevention and treatment after recurrence.
